Related Experiment Video

Updated: Oct 19, 2025

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.9K

Smartphone monitoring for Parkinson's disease

Karen O'Leary

    Nature Medicine
    |September 18, 2021
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    BiotechnologyParkinson's disease

    More Related Videos

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    15.4K
    Video Movement Analysis Using Smartphones ViMAS: A Pilot Study
    07:51

    Video Movement Analysis Using Smartphones ViMAS: A Pilot Study

    Published on: March 14, 2017

    17.0K

    Related Experiment Videos

    Last Updated: Oct 19, 2025

    Home-Based Monitor for Gait and Activity Analysis
    07:24

    Home-Based Monitor for Gait and Activity Analysis

    Published on: August 8, 2019

    6.9K
    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    15.4K
    Video Movement Analysis Using Smartphones ViMAS: A Pilot Study
    07:51

    Video Movement Analysis Using Smartphones ViMAS: A Pilot Study

    Published on: March 14, 2017

    17.0K

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    447
    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    447
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    854
    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
    854
    Neural Regulation01:37

    Neural Regulation

    40.6K
    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
    40.6K

    Articles linked to this work by shared authors, journal, and citation graph.

    Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC.

    Nature medicine·2026

    Joint impact of pathological burden and cognitive resilience on Alzheimer's disease risk.

    Nature medicine·2026

    Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial.

    Nature medicine·2026

    A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.

    Nature medicine·2026

    COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer.

    Nature medicine·2026

    Phenomic profiles and disease patterns of 1.9 million participants from Our Future Health.

    Nature medicine·2026

    Intrinsic AIE drug nanocrystals enable imaging-guided orchitis theranostics.

    Materials today. Bio·2026

    Photoacoustic Nanotagging for In Vivo Tracking and Optimization of Macrophage Immunotherapy in Solid Tumors.

    Advanced materials (Deerfield Beach, Fla.)·2026

    Current Advancements of Orally Administered Nanomedicine: Disease Diagnosis and Therapy via Targeted Delivery.

    ACS biomaterials science & engineering·2026

    Telitacicept for primary angiitis of the central nervous system: A real-world retrospective study.

    Therapeutic advances in neurological disorders·2026

    Nanotheranostics in orthopedic diseases: a critical review of molecular diagnostic-driven targeted therapeutics for personalized patient care.

    Expert review of molecular diagnostics·2026

    Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation.

    International immunopharmacology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us